Filing Details
- Accession Number:
- 0001415889-24-025975
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-04 16:30:10
- Reporting Period:
- 2024-11-01
- Accepted Time:
- 2024-11-04 16:30:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1673232 | Michael Benkowitz | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | President And Coo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-01 | 14,700 | $120.26 | 14,700 | No | 4 | M | Indirect | By Trust |
Common Stock | Disposition | 2024-11-01 | 200 | $370.65 | 14,500 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2024-11-01 | 800 | $371.71 | 13,700 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2024-11-01 | 1,200 | $373.05 | 12,500 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2024-11-01 | 6,096 | $374.02 | 6,404 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2024-11-01 | 3,501 | $375.06 | 2,903 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2024-11-01 | 1,803 | $375.83 | 1,100 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2024-11-01 | 1,000 | $376.94 | 100 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2024-11-01 | 100 | $378.00 | 0 | No | 4 | S | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2024-11-01 | 14,700 | $0.00 | 14,700 | $120.26 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,500 | 2017-03-15 | 2026-03-15 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,577 | Direct |
Footnotes
- Reflects the exercise of options held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.
- This transaction was executed in multiple trades at prices ranging from $370.38 to $370.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $371.41 to $372.2775. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $372.434 to $373.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $373.4616 to $374.4129. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $374.47 to $375.4685. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $375.4825 to $376.3012. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $376.5701 to $377.2793. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.